As shown in Figure 5, the anti-CD8 Ab, which eliminated CD8+ cells in the tumor (Supplementary Figure 3), inhibited the reductions in liver weight and Ki67-positive area that was mediated by the combined treatment. This evidence concerns the gene MKI67 and neoplasm.